DexCom (DXCM) Worth Watching: Stock Moves 8.4% Higher – Tale of the Tape

January 27, 2015 Technicals 0

Zacks

DexCom, Inc. (DXCM) was a big mover last session, as the company saw its shares rise over 8% on the day. The upside was owing to the receipt of the FDA approval for its Dexcom G4 PLATINUM Continuous Glucose Monitoring System with Share. This development led to far more shares changing hands yesterday than in a normal session. The move breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $54.21 to $59.99.

This developer of continuous glucose monitoring systems has witnessed two positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Dexcom currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked stock in the Med-Instruments industry is ABIOMED, Inc. (ABMD) which carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply